Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis
Divya Ramchandani(Cornell University), Vivek Mittal(Cornell University), Justin R. Cross(Memorial Sloan Kettering Cancer Center), Dingcheng Gao(Cornell University), Mirela Berisa(Memorial Sloan Kettering Cancer Center), Suzanne M. Cloonan(Trinity College Dublin), Linda T. Vahdat(Dartmouth–Hitchcock Medical Center), Diamile A. Tavarez(Cornell University), Zhuoning Li(Memorial Sloan Kettering Cancer Center), Matthew M. Miele(Memorial Sloan Kettering Cancer Center), Noah Dephoure(Arup Group (United States)), Ronald C. Hendrickson(Memorial Sloan Kettering Cancer Center), Sharrell B. Lee(Cornell University), Yi Ban(Cornell University), Yang Bai(Cornell University)
Cited by 304
Related Papers
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
|Nature|2015|1.8k
A quantitative atlas of mitotic phosphorylation
|Proceedings of the National Academy of Sciences|2008|1.6k
Connecting copper and cancer: from transition metal signalling to metalloplasia
|Nature reviews. Cancer|2021|1.3k
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
|The Lancet|2011|1.1k
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
|New England Journal of Medicine|2019|846